EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Long‐term risk of major cardiac events in breast cancer patients treated with intensity‐modulated and 3‐dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial

Nam Kyu Kang, Kyu Hye Choi, Jae Uk Jeong, Sung Ja Ahn, Mina Yu, Jin Hee Kim, Bae Kwon Jeong, Han Byul Kang, Hyo Chun Lee, Jong Hoon Lee iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35476 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Nam Kyu Kang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiotherapy, Intensity-Modulated, Radiotherapy, Conformal, Heart. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We assess the relationship between radiation dose to the heart and cardiac disease within the context of modern radiotherapy techniques of 3‐dimensional and intensity‐modulated radiotherapy (IMRT). The KROG 15‐03 study was a multicenter phase III trial involving 693 breast cancer patients who underwent breast‐conserving surgery (BCS). Patients were randomly assigned to receive either IMRT or 3D‐CRT following BCS. Major cardiac event (MCE), defined as the occurrence of angina pectoris or myocardial infarction requiring coronary angiography, and admission for cardiac arrhythmia related to the irradiation of the heart. The primary outcome of the study was to investigate the incidence of MCE and factors associated with MCEs. At a median follow‐up of 6.5 years, the incidence of MCEs at 6.5 years was 1.8%. The mean heart dose (MHD) for the entire cohort of 647 patients was 2.1 (±2.3) Gy. The cumulative incidence of MCEs at 6.5 years was 1.1% for the subgroup of MHD 2.9 Gy ( p = 0.010), and 0.9% for the subgroup of age ≤55 years and 3.3% for the subgroup of age >55 years ( p = 0.006), respectively. Multivariate analyses confirmed that MHD ( p = 0.044; hazard ratio [HR], 1.21 per 1 Gy; 95% confidence interval [CI], 1.09–1.46) and age ( p = 0.034; HR, 1.07 per 1 year; 95% CI, 1.03–1.14) were significant factors of MCEs. The incidence of MCE increased by 21% per 1‐Gy increase in MHD within 6.5 years after radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy, ConformalHeartHumansFemaleMiddle AgedAgedAdultMastectomy, SegmentalFollow-Up StudiesRadiotherapy DosageIncidence

Stichwörter der Autor:innen

breast cancercardiac eventmodern radiotherapyrisk

Autor:innen und Institutionen

  • Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Republic of Korea.
  • Department of Radiation Oncology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.

ORCID-Profile: Jong Hoon Lee

Zitieren

APA

Kang, N. K., Choi, K. H., Jeong, J. U., Ahn, S. J., Yu, M., Kim, J. H., Jeong, B. K., Kang, H. B., Lee, H. C., & Lee, J. H. (2025). Long‐term risk of major cardiac events in breast cancer patients treated with intensity‐modulated and 3‐dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial. International Journal of Cancer. https://doi.org/10.1002/ijc.35476

Vancouver

Kang NK, Choi KH, Jeong JU, Ahn SJ, Yu M, Kim JH, et al. Long‐term risk of major cardiac events in breast cancer patients treated with intensity‐modulated and 3‐dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial. International Journal of Cancer. 2025. doi:10.1002/ijc.35476

BibTeX
@article{Kang2025,
  author = {Kang, Nam Kyu and Choi, Kyu Hye and Jeong, Jae Uk and Ahn, Sung Ja and Yu, Mina and Kim, Jin Hee and Jeong, Bae Kwon and Kang, Han Byul and Lee, Hyo Chun and Lee, Jong Hoon},
  title = {Long‐term risk of major cardiac events in breast cancer patients treated with intensity‐modulated and 3‐dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35476}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche